Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2881 - 2888 of 12086 results

Breaking Down the New COVID-19 Safety Protocol Guidance for Federal Contractors and Subcontractors
October 1, 2021| Blog| Viewpoint

Custom Servers Pin Netflix In the Eastern District of Texas
September 30, 2021| Blog| Viewpoint

Stakeholders Speak: Leahy Bill to ‘Restore the AIA’ is Too Unbalanced to Pass
September 30, 2021| News

Artificial Intelligence in the Workplace and The Future of Employer-Provided Employee Benefits
September 30, 2021| News

Have You Updated Your HIPAA Security Risk Assessment Lately?
September 29, 2021| Blog| Viewpoint

PBM Regulatory Landscape Roundup (Summer 2021): A Flurry of Regulations, Rutledge, and a Crucial 8th Circuit Decision
September 28, 2021| Blog| Viewpoint

Not Cleared for Takeoff: DOJ Sues to Stop American-JetBlue Alliance in the Northeast
September 27, 2021| Blog| Viewpoint

Five Takeaways from DOJ’s Latest National Enforcement Action, Including Continued Focus on Opioids and Telemedicine
September 27, 2021| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
